Re: Consumption of Virgin Olive Oil Represses the in vivo Expression of Pro-Inflammatory Genes in Patients with Metabolic Syndrome
Camargo A, Ruano J, Fernandez JM, et al. Gene expression changes in mononuclear cells from patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics. 2010;11:253.DOI: 10.1186/1471-2164-11-253.
Human,
animal, and in vitro studies have shown that the acute intake of virgin olive
oil (Olea europaea) with a high
phenol content results in a greater reduction in pro-inflammatory, pro-oxidant,
and pro-thrombotic markers than does consumption of virgin olive oil with a low
phenol content. These studies showed that olive oil modified gene expression
coding for proteins involved in cellular mechanisms related to oxidative stress
resistance, lipid metabolism, and other mechanisms associated with
atherosclerosis development. However, it is not known whether these changes in
gene expression are attributable to oleic acid or to polar minor components of
olive oil, possibly as a consequence of their antioxidant activity or through a
direct interaction with receptors, enzymes, or transcription factors. Thus, the
objective of the present randomized, double-blind, crossover study was to
identify those genes that undergo changes in expression in peripheral blood
mononuclear cells (PBMCs) in patients with metabolic syndrome.
Twenty
subjects (9 men and 11 women) from the Lipids and Atherosclerosis Unit at the
Hospital Universitario Reina Sofia (Cordoba,
Spain) who met
at least 3 of the criteria for a diagnosis of metabolic syndrome, but had no
chronic diseases, participated in this study. The 5 criteria used for metabolic
syndrome were central obesity, high blood pressure or antihypertensive therapy,
high fasting glucose, hypertriglyceridemia, and a low level of high-density-lipoprotein
cholesterol. After a 6-week washout period, during which the subjects were
instructed to abstain from vitamin, soy supplement, and drug intake, they were
randomly assigned to consume a virgin olive oil-based breakfast meal (40 mL
virgin olive oil; CANOLIVA®; Antonio Cano e Hijos; Cordoba, Spain)
with either a low (70 ppm) or a high (398 ppm) content of phenolic compounds
together with 60 g of white bread. All subjects maintained a low-fat,
carbohydrate-rich diet throughout the study to eliminate the potential effect
of usual dietary habits. Crossover followed a 1-week washout period between
breakfasts. A 24-hour avoidance of phenol-rich food included a 12-hour fast
just prior to each breakfast. Compliance was evaluated by reviewing dietary
records and food-frequency questionnaires completed by the participants.
Venous
blood samples were collected 0, 30, 60, 120, and 240 minutes after the consumption
of the breakfast meal for the measurement of non-esterified fatty acids,
triglycerides, high-density-lipoprotein cholesterol, glucose, and insulin. Areas
under the curve (AUCs) for these variables were calculated and compared between
the 2 interventions. PBMCs were isolated within 2 hours of blood collection for
a gene expression microarray analysis. Total RNA was extracted from the PBMCs,
purified, and then quantified. Each microarray analysis involved a comparison
of total RNA from PBMCs obtained after intake of olive oil with a high phenol
content with that after intake of olive oil with a low phenol content.
No
significant differences in the AUCs for non-esterified fatty acids,
triglycerides, high-density-lipoprotein cholesterol, glucose, or insulin were
observed between the 2 interventions. A total of 98 genes were found to be
differentially expressed in human PBMCs following use of phenol-rich olive oil
(P ≤ 0.01), 79 of which were underexpressed and 19 of which were overexpressed.
The most underexpressed genes (1.95- to 2.74-fold) were as follows: G0S2, EGR2, EGR1, FOSB, IL1B, NR4A2, EGR3,
RASGEF1B, CXCL1, and PTGS2. The
most overexpressed genes (1.46- to 1.57-fold) were as follows: CA1, RAP1GAP, GYPB, FN1, and SELENBP1. A sex analysis showed that 32
genes were differentially expressed in both men and women; 218 genes were
differentially expressed only in men, and 111 genes were differentially
expressed only in women. Many of these genes are known to be linked to type 2
diabetes, obesity, and dyslipidemia or are involved in inflammatory processes
mediated by transcription factor NF-kB, activator protein-1 transcription
factor complex AP-1, cytokines, mitogen-activated protein kinases, or
arachidonic acid pathways.
The results
of this study indicate that the consumption of virgin olive oil rich in
phenolic compounds repressed the in vivo expression of several pro-inflammatory
genes, which consequently diminished the inflammatory profile of PBMCs. The
authors conclude that the “results provide at least a partial molecular basis
for [a] reduced risk of cardiovascular disease observed in Mediterranean
countries, where virgin olive oil represents a main source of dietary fat.”
Further research is necessary to determine whether prolonged feeding maintains
these effects. It remains undetermined whether one or several phenolic
components are primarily responsible for these benefits, or if the entire
phenolic fraction has synergistic effects.